Pulished : February, 2020
ID: 23
Region: Global
Share on

Global Acute Ischemic Stroke Diagnosis and Treatment Market Size Worth USD 3047 Mn by 2024

Pulished: February, 2020
ID: 23
Share on

According to the report, the Global Acute Ischemic Stroke Diagnosis and Treatment Market is estimated to be USD 2203.59 million in 2019 and predicted to rise to USD 3047.56 million by 2024, with a CAGR of 6.7%.

 

The Acute Ischemic Stroke Treatment and Diagnosis Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc.

 

The market is segmented by Diagnostic type (Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Cerebral angiography, and Nuclear Imaging), Surgery Type (Angioplasty, Carotid Endarterectomy, and Endovascular Mechanical Thrombectomy). Further, the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America, and Middle-East & Africa.

 

The rising prevalence of acute ischemia stroke cases is driving the demand for surgical procedures in acute stroke treatment. Advancements in surgical procedures along with the growing geriatric population, increasing demand for minimally invasive procedures and growth in healthcare expenditure are the key factors boosting the growth of the Global Acute Ischemic Stroke Diagnosis and treatment market. The high cost of surgical procedures and excessive usage of medication for the treatment of ischemic stroke are hindering the market growth. Carotid Endarterectomy is the largest segment accounting for a significant share owing to a high success rate, short treatment duration, and easy availability.

 

North America is the largest market for Acute Ischemic Stroke Diagnosis and Treatment devices are estimated to continue its stronghold of the market owing to favorable government initiatives, technological innovations and increasing demand for ischemic stroke products. Asia-Pacific is the most promising market for acute ischemic stroke diagnosis owing to the increasing prevalence of ischemic stroke cases in this region. Manufacturers are expanding their operations in the Asia-Pacific region as these regions hold immense potential for the market growth

 

Some of the major companies covered in the report are Abbott Laboratories, Covidien plc, Philips Healthcare, Johnson & Johnson, Penumbra, Inc., GE Healthcare, Siemens Healthcare, Stryker Corporation (Concentric Medical, Inc.) and Hitachi, Ltd.

 

Browse Regional Reports: